Cervical Cancer Prevention

Detalhes bibliográficos
Autor(a) principal: Alves dos Santos, Carla
Data de Publicação: 2010
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.31877/on.2010.12.02
Resumo: Cervical cancer has a major impact on the lives of women worldwide. Although cancer is common in the elderly, cervical cancer mainly affects young women, between 35 and 50, many with work and family responsibilities. In the European Union, about 34,000 new cases and 16,000 deaths from cervical cancer are reported annually(1).Within all cancers, cervical cancer is the one which can be most effectively controlled, having a great potential for prevention and cure.Cervical cancer can be prevented through primary prevention strategies, through vaccination, which aims to prevent the transmission of the virus (HPV-16 and -18) necessary to the disease development, and secondary prevention strategies, through a screening test (Pap test or HPV), in order to detect pre-invasive lesions and prevent the onset of cancer
id RCAP_afc5c7282e0eb45349e92efb6d8f9d7f
oai_identifier_str oai:oai.onco.news:article/231
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Cervical Cancer PreventionPrevenção do Cancro do Colo do ÚteroCancro do colo do úteroprevenção do cancro do colo do úterorastreio e vacinaçãoCervical cancerprevention of cervical cancerscreening and vaccinationCervical cancer has a major impact on the lives of women worldwide. Although cancer is common in the elderly, cervical cancer mainly affects young women, between 35 and 50, many with work and family responsibilities. In the European Union, about 34,000 new cases and 16,000 deaths from cervical cancer are reported annually(1).Within all cancers, cervical cancer is the one which can be most effectively controlled, having a great potential for prevention and cure.Cervical cancer can be prevented through primary prevention strategies, through vaccination, which aims to prevent the transmission of the virus (HPV-16 and -18) necessary to the disease development, and secondary prevention strategies, through a screening test (Pap test or HPV), in order to detect pre-invasive lesions and prevent the onset of cancerO cancro do colo do útero apresenta um importante impacto na vida das mulheres em todo o mundo, pois, embora o cancro seja mais frequente em pessoas idosas, o cancro do colo do útero afecta maioritariamente mulheres jovens, em idade activa, entre 35 e 50 anos, muitas das quais com responsabilidades profissionais e familiares. São reportados, anualmente, na União Europeia, cerca de 34.000 novos casos e 16.000 mortes por cancro do colo do útero(1).De todos os cancros, o cancro do colo do útero é o que apresenta um dos mais elevados potenciais de prevenção e cura, aquele que pode ser controlado com maior efectividade.Na prevenção do cancro do colo do útero podem ser utilizadas estratégias de prevenção primária, através da vacinação, que tem como objectivo impedir a transmissão do agente (HPV-16 e -18), indispensável ao desenvolvimento da doença, e estratégias de prevenção secundária, através de um teste de rastreio (citologia ou teste de HPV), com o intuito de detectar as lesões pré-invasivas e impedir o aparecimento de cancro.AEOP – Associação de Enfermagem Oncológica Portuguesa2010-03-03info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.31877/on.2010.12.02https://doi.org/10.31877/on.2010.12.02Onco.news; No. 12 (2009): Onco.News Journal; 14-19Onco.News; N.º 12 (2009): Revista Onco.News; 14-192183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/231https://onco.news/index.php/journal/article/view/231/232Direitos de Autor (c) 2023 Carla Alves dos Santosinfo:eu-repo/semantics/openAccessAlves dos Santos, Carla2023-08-26T07:25:22ZPortal AgregadorONG
dc.title.none.fl_str_mv Cervical Cancer Prevention
Prevenção do Cancro do Colo do Útero
title Cervical Cancer Prevention
spellingShingle Cervical Cancer Prevention
Alves dos Santos, Carla
Cancro do colo do útero
prevenção do cancro do colo do útero
rastreio e vacinação
Cervical cancer
prevention of cervical cancer
screening and vaccination
title_short Cervical Cancer Prevention
title_full Cervical Cancer Prevention
title_fullStr Cervical Cancer Prevention
title_full_unstemmed Cervical Cancer Prevention
title_sort Cervical Cancer Prevention
author Alves dos Santos, Carla
author_facet Alves dos Santos, Carla
author_role author
dc.contributor.author.fl_str_mv Alves dos Santos, Carla
dc.subject.por.fl_str_mv Cancro do colo do útero
prevenção do cancro do colo do útero
rastreio e vacinação
Cervical cancer
prevention of cervical cancer
screening and vaccination
topic Cancro do colo do útero
prevenção do cancro do colo do útero
rastreio e vacinação
Cervical cancer
prevention of cervical cancer
screening and vaccination
description Cervical cancer has a major impact on the lives of women worldwide. Although cancer is common in the elderly, cervical cancer mainly affects young women, between 35 and 50, many with work and family responsibilities. In the European Union, about 34,000 new cases and 16,000 deaths from cervical cancer are reported annually(1).Within all cancers, cervical cancer is the one which can be most effectively controlled, having a great potential for prevention and cure.Cervical cancer can be prevented through primary prevention strategies, through vaccination, which aims to prevent the transmission of the virus (HPV-16 and -18) necessary to the disease development, and secondary prevention strategies, through a screening test (Pap test or HPV), in order to detect pre-invasive lesions and prevent the onset of cancer
publishDate 2010
dc.date.none.fl_str_mv 2010-03-03
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.31877/on.2010.12.02
https://doi.org/10.31877/on.2010.12.02
url https://doi.org/10.31877/on.2010.12.02
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://onco.news/index.php/journal/article/view/231
https://onco.news/index.php/journal/article/view/231/232
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 Carla Alves dos Santos
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 Carla Alves dos Santos
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
dc.source.none.fl_str_mv Onco.news; No. 12 (2009): Onco.News Journal; 14-19
Onco.News; N.º 12 (2009): Revista Onco.News; 14-19
2183-6914
1646-7868
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777304682503340032

Registros relacionados